Saluda Medical(ASX) SLD

Market CapA$104.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-68%
5 YearN/A
1 YearN/A
1 Month-6%
A$0.42
+2.47%
+0.01Today
Saluda Medical last closing stock price
MetricPriceDate
Last closeAUD 0.422026-10-12
Saluda Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.19%AUD 0.422026-10-05
1 month-5.68%AUD 0.442026-09-11
3 month-20.95%AUD 0.532026-07-14
Year to date-70.88%AUD 1.432025-12-31
Since inception-68.11%AUD 1.272025-12-05

Saluda Medical Financials at a Glance

Market Cap

A$104.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-A$0.87

P/E Ratio

-0.48

Dividend

A$0.00

Beta (Volatility)

-0.81 (Low)

Price

A$0.42

Volume

88,460

Open

A$0.42

Previous Close

A$0.42

Daily Range

A$0.41 - A$0.44

52-Week Range

A$0.36 - A$1.90

Estimated Earnings Date

Aug 27, 2026

SLD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Saluda Medical

Saluda Medical, Inc. is a medical device company focused on developing innovative treatments for chronic neurological conditions. The company operates in the United States, Australia, Europe, and internationally, offering advanced solutions to improve patient outcomes.

Products and Services
  • Closed-loop, dose-control platform for real-time neurophysiological feedback
  • Evoke device for managing chronic intractable pain
  • Spinal cord stimulation therapy to optimize treatment and reduce burden
Growth Outlook
  • Significant market potential in chronic pain management sector
  • Expansion into international markets enhances revenue opportunities
  • Innovative technology positions the company for future growth
Financial Highlights
  • Market capitalization of AUD 102 million indicates strong investor interest
  • Stock price range between AUD 0.36 and AUD 1.9 shows potential for growth
  • Recent trading volume of 187,761 reflects active market engagement
Saluda Medical, Inc. is well-positioned in the healthcare sector, particularly in the medical devices industry. The company's innovative approach to treating chronic pain through advanced technology offers a competitive edge. With a focus on real-time feedback and optimization of therapy, Saluda Medical aims to enhance patient care while addressing significant market needs. The growth outlook remains promising, supported by expansion strategies and a commitment to innovation. Financial highlights indicate a solid market presence, with a notable market capitalization and active trading volume, suggesting investor confidence in the company's future prospects.
AI Generated • Sep 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Barry John Regan, MBA

Headquarters

Bloomington, MN 55431, US

SLD Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-2.08%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

A$104.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

252.02M

Volume

88.46K

Avg. Volume

404.44K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Saluda Medical Performance Analysis

Saluda Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 33,051,676N/A
20242024-06-30AUD 78,858,675138.6%
20252025-06-30AUD 108,635,98337.8%
20262026-06-30AUD 133,075,56222.5%
Saluda Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.54N/A
20242024-06-30AUD -0.599.0%
20252025-06-30AUD -0.9154.4%
20262026-06-30AUD -2.18138.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

A$104.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EBR.AXEBR Systems, Inc.
A$0.14-40.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$36.59+6.40%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$130.52-6.62%
GIXIGix Internet
$5.47+40.62%
IRENIren
$35.93+2.09%

Questions About SLD

What is the current price of Saluda Medical?

Saluda Medical is trading at A$0.42 per share.

What is the 52-week range for Saluda Medical?

Over the past 52 weeks, Saluda Medical has traded between A$0.36 and A$1.90.

How much debt does Saluda Medical have?

As of the most recent reporting period, Saluda Medical reported total debt of A$143.98M.

How much cash does Saluda Medical have on hand?

Saluda Medical reported A$171.21M in cash and cash equivalents in its most recent financial results.

What is Saluda Medical’s dividend yield?

Saluda Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services